Search
nebivolol (Bystolic)
Tradename: Bystolic. FDA approved 2007
Indications:
- hypertension
- angina pectoris [2]
- chronic heart failure
- rate control in atrial fibrillation
- secondary prevention in patients with cardiovascular disease [2]
Adverse effects:
- headache
- fatigue
- dizziness
- diarrhea
Mechanism of action:
- beta-1 adrenergic receptor antagonist
- vasodilating effects
Interactions
drug adverse effects of beta-adrenergic receptor antagonists
General
beta-1 adrenergic receptor antagonist (beta-1 blocker)
References
- Weiss RJ et al,
A randomized, double-blind, placebo-controlled parallel group
study to assess the efficacy and safety of nebivolol, a novel
beta-blocker, in patients with mild to moderate hypertension
J Clin Hypertens 2007, 9:667
PMID: 17786067
- Deprecated Reference